Episode 108: ASCO 2024 - Metastatic Breast Cancer

Today, Michael and Josh approach a singular destiny to present their take on Metastatic Breast Cancer at ASCO 2024. Long has Breast Cancer been one of the most diagnosed cancers globally; these days, it leads the herd with effective treatment options and paradigm shifts that benefit millions of people on a massive scale. With CDK4/6 inhibitors, immunotherapy and antibody-drug conjugates, the arsenal of effective treatment tools continues to grow! Nothing excites an oncologist more than a good randomised phase 3 international study. Today, they present the following:

Links to studies discussed (subscription may be required):

Destiny-Breast06: Link

postMONARCH: Link

INAVO120: Link

OptiTROP-Breast01: Link